{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:32:03Z","timestamp":1759073523428,"version":"3.40.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.mehy.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T17:30:49Z","timestamp":1384191049000},"page":"49-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Altered autonomic inputs as a cause of pancreatic \u03b2-cell amyloid"],"prefix":"10.1016","volume":"82","author":[{"given":"Milind","family":"Watve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arushi","family":"Bodas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manawa","family":"Diwekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0010","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.2337\/diabetes.50.2007.S160","article-title":"Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms","volume":"50","author":"Porte","year":"2001","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.mehy.2013.11.002_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00403322","article-title":"Islet amyloid polypeptide in diabetic and non-diabetic pima indians","volume":"33","author":"Clark","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2013.11.002_b0020","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF00274799","article-title":"Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals","volume":"30","author":"Westermark","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2013.11.002_b0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00125-008-0936-9","article-title":"Beta cell mass in diabetes: a realistic therapeutic target?","volume":"51","author":"Meier","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2013.11.002_b0030","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1021\/ja900285z","article-title":"Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy","volume":"131","author":"Soong","year":"2009","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mehy.2013.11.002_b0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","article-title":"Islet amyloid and type 2 diabetes mellitus","volume":"343","author":"H\u00f6ppener","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2013.11.002_b0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr Rev"},{"issue":"17","key":"10.1016\/j.mehy.2013.11.002_b0045","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J Biol Chem."},{"key":"10.1016\/j.mehy.2013.11.002_b0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0055","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1111\/j.1742-4658.2006.05367.x","article-title":"The aggregation potential of human amylin determines its cytotoxicity towards islet beta-cells","volume":"273","author":"Konarkowska","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.mehy.2013.11.002_b0060","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diabetes.52.7.1701","article-title":"Replication increases \u03b2-cell vulnerability to human islet amyloid polypeptide-induced apoptosis","volume":"52","author":"Ritzel","year":"2003","journal-title":"Diabetes"},{"issue":"14","key":"10.1016\/j.mehy.2013.11.002_b0065","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2013.11.002_b0070","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased \u03b2-cell apoptosis prevents adaptive increase in \u03b2-cell mass in mouse model of type 2 diabetes evidence for role of islet amyloid Formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF00285291","article-title":"Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets","volume":"32","author":"Lukinius","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2013.11.002_b0080","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0085","first-page":"1","article-title":"Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase\u2013antiperoxidase (PAP) and protein a-gold techniques","volume":"130","author":"Johnson","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.mehy.2013.11.002_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1699-0463.1996.tb00680.x","article-title":"Islet amyloid in type 2 (non-insulin-dependent) diabetes","volume":"104","author":"Clark","year":"1996","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"issue":"11","key":"10.1016\/j.mehy.2013.11.002_b0095","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1210\/mend-3-11-1775","article-title":"Human islet amyloid polypeptide gene: complete nucleotide sequence, chromosomal localization, and evolutionary history","volume":"3","author":"Nishi","year":"1989","journal-title":"Mol Endocrinol Baltim Md"},{"issue":"2","key":"10.1016\/j.mehy.2013.11.002_b0100","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0014-4827(89)90407-2","article-title":"Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus","volume":"183","author":"Betsholtz","year":"1989","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.mehy.2013.11.002_b0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-5793(95)01460-8","article-title":"Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2","volume":"378","author":"Badman","year":"1996","journal-title":"FEBS Lett"},{"issue":"16","key":"10.1016\/j.mehy.2013.11.002_b0110","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1046\/j.1432-1327.2000.01548.x","article-title":"Processing of synthetic pro-islet amyloid polypeptide (proIAPP) \u2018amylin\u2019 by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro","volume":"267","author":"Higham","year":"2000","journal-title":"Eur J Biochem FEBS"},{"issue":"3","key":"10.1016\/j.mehy.2013.11.002_b0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","article-title":"The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site","volume":"50","author":"Wang","year":"2001","journal-title":"Diabetes."},{"issue":"Pt 2","key":"10.1016\/j.mehy.2013.11.002_b0120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/bj2850391","article-title":"A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase","volume":"285","author":"Bailyes","year":"1992","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","article-title":"Role of \u03b2-cell prohormone convertase (PC)1\/3 in processing of pro-islet amyloid polypeptide","volume":"53","author":"Marzban","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.mehy.2013.11.002_b0135","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diab.39.6.752","article-title":"Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans","volume":"39","author":"Butler","year":"1990","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0140","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1152\/ajpendo.00242.2009","article-title":"Fatty acids induce amylin expression and secretion by pancreatic \u03b2-cells","volume":"298","author":"Qi","year":"2010","journal-title":"Am J Physiol \u2013 Endocrinol Metab"},{"key":"10.1016\/j.mehy.2013.11.002_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1152\/advan.00167.2012","article-title":"Interactions between the central nervous system and pancreatic islet secretions: a historical perspective","volume":"37","author":"Begg","year":"2013","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.mehy.2013.11.002_b0150","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2013.11.002_b0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","article-title":"Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species","volume":"251","author":"Betsholtz","year":"1989","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbadis.2005.02.001","article-title":"Islet amyloid polypeptide gene promoter polymorphisms are not associated with type 2 diabetes or with the severity of islet amyloidosis","volume":"1740","author":"Esapa","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.mehy.2013.11.002_b0165","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.febslet.2013.01.046","article-title":"Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity","volume":"587","author":"Cao","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2013.11.002_b0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jmb.2005.10.052","article-title":"Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP?","volume":"355","author":"Abedini","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mehy.2013.11.002_b0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/protein\/gzm076","article-title":"Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide","volume":"21","author":"Koo","year":"2008","journal-title":"Protein Eng Des Sel PEDS"},{"key":"10.1016\/j.mehy.2013.11.002_b0180","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2337\/diabetes.49.12.2056","article-title":"Beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes","volume":"49","author":"Andrikopoulos","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/BF00417699","article-title":"Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro","volume":"37","author":"Verchere","year":"1994","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.mehy.2013.11.002_b0190","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"Verchere","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2013.11.002_b0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0925-4439(01)00078-3","article-title":"Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology","volume":"1537","author":"Jaikaran","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.mehy.2013.11.002_b0200","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am J Pathol"},{"issue":"28","key":"10.1016\/j.mehy.2013.11.002_b0205","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1073\/pnas.1209527109","article-title":"Conserved features of intermediates in amyloid assembly determine their benign or toxic states","volume":"109","author":"Krishnan","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.mehy.2013.11.002_b0210","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2337\/db06-1579","article-title":"Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP\u2013induced \u03b2-Cell apoptosis in h-IAPP transgenic mice","volume":"56","author":"Lin","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsb.2009.06.020","article-title":"Conformation and topology of amyloid beta-protein adsorbed on a tethered artificial membrane probed by surface plasmon field-enhanced fluorescence spectroscopy","volume":"168","author":"Song","year":"2009","journal-title":"J Struct Biol"},{"key":"10.1016\/j.mehy.2013.11.002_b0220","doi-asserted-by":"crossref","first-page":"12277","DOI":"10.1073\/pnas.95.21.12277","article-title":"Temperature dependence of amyloid {beta}-protein fibrillization","volume":"95","author":"Kusumoto","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.mehy.2013.11.002_b0225","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/bi300574r","article-title":"Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects","volume":"51","author":"Marek","year":"2012","journal-title":"Biochem (Mosc)"},{"key":"10.1016\/j.mehy.2013.11.002_b0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/030098589303000401","article-title":"Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus","volume":"30","author":"O\u2019Brien","year":"1993","journal-title":"Vet Pathol"},{"key":"10.1016\/j.mehy.2013.11.002_b0235","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.49.12.2094","article-title":"A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia","volume":"49","author":"Weyer","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diab.35.3.258","article-title":"Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites","volume":"35","author":"Garvey","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2013.11.002_b0245","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0026-0495(76)90109-8","article-title":"The development of obesity, hyperinsulinemia, and hyperglycemia in ob\/ob mice","volume":"25","author":"Dubuc","year":"1976","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2013.11.002_b0250","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jn\/111.10.1742","article-title":"Non-essential role of dietary factors in the development of diabetes in ob\/ob mice","volume":"111","author":"Dubuc","year":"1981","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2013.11.002_b0255","first-page":"217","article-title":"The central nervous system-endocrine pancreas axis","volume":"44","author":"Rohner-Jeanrenaud","year":"1983","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.mehy.2013.11.002_b0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0002-9343(77)90538-1","article-title":"Circulating proinsulin in patients with maturity onset diabetes","volume":"63","author":"Mako","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.mehy.2013.11.002_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2013.01.013","article-title":"From pancreatic islet formation to beta-cell regeneration","author":"Ben-Othman","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.mehy.2013.11.002_b0270","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/BF00418372","article-title":"Beta-cell proliferation in normal and streptozotocin-treated newborn rats: site, dynamics and capacity","volume":"37","author":"Wang","year":"1994","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.mehy.2013.11.002_b0275","doi-asserted-by":"crossref","first-page":"354S","DOI":"10.1093\/jn\/131.2.354S","article-title":"Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity","volume":"131","author":"Kahn","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.mehy.2013.11.002_b0280","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/db12-1326","article-title":"\u03b2-cell failure in type 2 diabetes: a case of asking too much of too few?","volume":"62","author":"Costes","year":"2013","journal-title":"Diabetes"},{"year":"2013","series-title":"Doves, diplomats, and diabetes: a Darwinian interpretation of type 2 diabetes and related disorders","author":"Watve","key":"10.1016\/j.mehy.2013.11.002_b0285"},{"key":"10.1016\/j.mehy.2013.11.002_b0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2148-7-61","article-title":"Evolutionary origins of insulin resistance: a behavioral switch hypothesis","volume":"7","author":"Watve","year":"2007","journal-title":"BMC Evol Biol"},{"issue":"2","key":"10.1016\/j.mehy.2013.11.002_b0295","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neubiorev.2004.03.002","article-title":"The selfish brain: competition for energy resources","volume":"28","author":"Peters","year":"2004","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.mehy.2013.11.002_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1022598900246","article-title":"Brain insulin: regulation, mechanisms of action and functions","volume":"23","author":"Gerozissis","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.mehy.2013.11.002_b0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.02.057","article-title":"Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface","volume":"490","author":"Biessels","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2013.11.002_b0310","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI117483","article-title":"Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic beta cell in rats","volume":"94","author":"N\u2019Guyen","year":"1994","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.mehy.2013.11.002_b0315","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.ijo.0800523","article-title":"Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects","volume":"21","author":"Del Rio","year":"1997","journal-title":"Int J Obes Relat Metab Disord J Int Assoc Study Obes"},{"issue":"1","key":"10.1016\/j.mehy.2013.11.002_b0320","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0026-0495(97)90175-X","article-title":"Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL\/6J mice","volume":"46","author":"Ahr\u00e9n","year":"1997","journal-title":"Metabolism."},{"key":"10.1016\/j.mehy.2013.11.002_b0325","doi-asserted-by":"crossref","first-page":"F702","DOI":"10.1152\/ajprenal.00065.2006","article-title":"Glucose transporters in animal models of diabetes and hypertension","volume":"291","author":"Schaan","year":"2006","journal-title":"Am J Physiol \u2013 Ren Physiol"},{"key":"10.1016\/j.mehy.2013.11.002_b0330","doi-asserted-by":"crossref","first-page":"E1069","DOI":"10.1152\/ajpendo.00477.2006","article-title":"Role of the autonomic nervous system in the development of hyperinsulinemia by high-carbohydrate formula feeding to neonatal rats","volume":"292","author":"Mitrani","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mehy.2013.11.002_b0335","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF02065429","article-title":"Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy","volume":"40","author":"Glasbrenner","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mehy.2013.11.002_b0340","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/diab.34.11.1181","article-title":"Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy","volume":"34","author":"Buysschaert","year":"1985","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.mehy.2013.11.002_b0345","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/BF02221678","article-title":"Glucagon, insulin and somatostatin secretion in response to sympathetic neural activation in streptozotocin-induced diabetic rats. A study with the isolated perfused rat pancreas in vitro","volume":"35","author":"Kurose","year":"1992","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.mehy.2013.11.002_b0350","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/db05-1602","article-title":"Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic \u03b2-cell mass and function in a rodent model of type 2 diabetes","volume":"55","author":"Mu","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.mehy.2013.11.002_b0355","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF03401591","article-title":"Amyloid formation in response to beta cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide","volume":"1","author":"Westermark","year":"1995","journal-title":"Mol Med Camb Mass"},{"issue":"4","key":"10.1016\/j.mehy.2013.11.002_b0360","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/13506120600960734","article-title":"An in vitro model of early islet amyloid polypeptide (IAPP) fibrillogenesis using human IAPP-transgenic mouse islets","volume":"13","author":"Henson","year":"2006","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T20:11:09Z","timestamp":1746043869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713005185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0306987713005185"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.002","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered autonomic inputs as a cause of pancreatic \u03b2-cell amyloid","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}